Summary

Esophageal atresia (EA) is a life-threatening congenital malformation of the esophagus. Despite considerable recent advances in perinatal resuscitation and neonatal care, EA remains an important cause of mortality and morbidity, especially in low-income countries. The aim of this study was to assess risk factors for adverse outcomes following surgical repair of EA at a single center in Tunisia. We performed a retrospective analysis using medical records of neonates with surgical management of EA at our institution from 1 January 2007 to 31 December 2021. In total, 88 neonates were included with a mortality rate of 25%. There were 29 girls and 59 boys. The diagnosis of EA was suspected prenatally in 19 patients. The most common associated anomalies were congenital heart diseases. Prematurity, low birth weight, outborn birth, age at admission >12 hours, congenital heart disease, postoperative sepsis, and anastomotic leak were risk factors for mortality following surgical repair of EA. Anastomotic tension was the only factor associated with short-term complications and the occurrence of short-term complications was predictive of mid-term complications. This study provides physicians and families with contemporary information regarding risk factors for adverse outcomes following surgical repair of EA. Thus, any effort to reduce these risk factors would be critical to improving patient outcomes and reducing cost. Future multi-institutional studies are needed to identify, investigate, and establish best practices and clinical care guidelines for neonates with EA.

INTRODUCTION

Congenital anomalies are a major public health burden. Over 95% of deaths from congenital malformations occur in low-income and middle-income countries.1,2 Esophageal atresia (EA) is a life-threatening congenital malformation of the esophagus. The true incidence of EA is still unknown due to the lack of robust epidemiologic data. Several authors estimate that EA affects 1/2500 to 1/4500 live births.3–6 Despite considerable recent advances in perinatal resuscitation and neonatal care, EA remains an important cause of mortality and morbidity, especially in low-income countries.7–14 The aim of this study was to assess risk factors for adverse outcomes following surgical repair of EA at a single center in Tunisia.

METHODS

Subjects

We conducted a retrospective data collection through a review of the patients’ medical records. Ninety-five neonates with a surgical management of EA between 1 January 2007 and 31 December 2021 were included. Incomplete medical records represented the exclusion criteria from this study. The Ethical Committee of the Hedi Chaker University Hospital, Sfax, Tunisia, approved the study (HCH/022/0239).

Patients’ management

Preoperative management

The confirmation of the diagnosis of EA was made using a simple chest X-ray with a gastric tube inserted on the upper esophageal pouch. Once the diagnosis of EA has been established, continuous salivary suction from the upper pouch was done. In our institution, all patients with EA underwent echocardiography. However, preoperative tracheobronchoscopy was not performed because of the nonavailability, in our country, of the necessary equipment to carry out this investigation. Patients with severe respiratory distress underwent intubation and mechanical ventilation. Gap length was measured based on preoperative chest X-ray or at the time of surgical exploration. An anatomic distance of three or more vertebral bodies between the ends of the upper and distal esophageal pouches defined long-gap EA.

Surgical management

Surgical repair of EA depended on the anatomical type. Ladd classification was used to specify the type of EA. Open thoracotomy with extrapleural approach was done in all the patients.

In our patients with type III, IV, or V EA, the procedure begins with the closure of the fistula. Then we accomplished esophageal continuity using a single-layer, end-to-end anastomosis with monofilament absorbable sutures. A transanastomotic tube was inserted and a chest drain was placed near the anastomosis for an early diagnosis of anastomotic leak. The chest drain is usually removed at the seventh postoperative day after performing contrast esophagography.

In our patients with type I and II EA, we performed esophagostomy and gastrostomy. After 6 months to 1 year, these patients will be candidates for esophageal replacement.

Postoperative management

Postoperatively, tracheal intubation was maintained for a minimum of 24 hours. Empiric postoperative antibiotics were prescribed for all patients. We defined anastomotic leak as the presence of saliva in the chest tube or a recorded diagnosis of anastomotic leak on the contrast esophagography report. The absence of an anastomotic leak on the contrast esophagography performed on the seventh postoperative day allowed the start of oral feeding. Before discharge, all patients underwent spinal X-ray and renal ultrasound. Thereafter, we will try to identify postoperative complications while ensuring a regular and prolonged follow-up of these patients. The need for dilatation within 1 year of establishing esophageal continuity defined esophageal anastomotic stricture.

Risk factors for adverse outcomes

We evaluated the following predictive factors for adverse outcomes in neonates with in EA: sex, gestational age, birth weight, inborn/outborn status, age at admission, congenital heart disease, VACTERL association (Vertebral, Anorectal, Cardiac, Tracheo-Esophageal, Renal, Limb), twin birth, preoperative mechanical ventilation, age at surgery, anastomotic tension, long gap, postoperative sepsis, anastomotic leak, and occurrence of short-term complications (STC). Adverse outcomes included postoperative mortality and morbidity. We defined STC as complications occurring during the first postoperative year. Mid-term complications (MTC) were defined as complications occurring during the second and the third postoperative years.

Statistical analysis

We performed statistical analyses using IBM SPSS Statistics, version 20.0. Significance was assumed with P-values <0.05. We used chi-square tests to compare categorical variables including preoperative, surgical, and postoperative variables between nonsurvivor versus survivor groups, STC versus non-STC groups, and MTC versus non-MTC groups. For continuous variables, we used Student’s t-tests.

RESULTS

Baseline information

In total, 95 neonates were included during the study period. Seven patients with incomplete medical records were excluded leaving 88 neonates for final analysis. There were 29 girls and 59 boys (sex ratio = 2). The diagnosis of EA was suspected prenatally in 19 (21.6%) patients based on fetal ultrasound results, including absent or small stomach (n = 4) and polyhydramnios (n = 18). Eight neonates were born from a twin pregnancy. The median gestational age was 38 weeks, (interquartile range [IQR], 36–39 weeks). Eighteen (20.4%) patients were premature. Twenty-five (28.4%) newborns weighed <2500 g. Forty-nine (55.7%) patients had associated malformations. The most common associated anomalies were congenital heart diseases (Table 1). The types of EA included types I (7.9%; n = 7), II (1.1%; n = 1), III (77.3%; n = 68), IV (4.5%; n = 4), and V (9.1%; n = 8). A primary anastomosis of the esophageal ends was done in all patients with short gap EA (n = 10; 11.4%). Seventy patients had an intermediate gap EA; of these patients, 15 (17%) patients had a low-tension anastomosis, and 55 (62.5%) had a nontension primary anastomosis. Eight (9.1%) neonates with long-gap EA underwent esophagostomy and gastrostomy.

Table 1

Incidence of associated anomalies in neonates with esophageal atresia

AnomalyNumber of cases (%)
Congenital heart disease35 (39.8%)
Ventricular septal defect15 (17%)
Atrial septal defect12 (13.6%)
Musculoskeletal23 (26.1%)
Vertebral abnormality13 (14.8%)
Limb abnormality9 (10.2%)
Genitourinary26 (25%)
Renal abnormality21 (23.9%)
Genital/urinary abnormality5 (1.1%)
Intestinal7 (8%)
Imperforate anus5 (5.7%)
Atresia2 (2.3)
Intracranial/cranial facial9 (10.2%)
Craniofacial abnormality5 (5.7%)
Chromosomal8 (9.1%)
Trisomy 212 (2.3%)
VACTERL association11 (12.5%)
AnomalyNumber of cases (%)
Congenital heart disease35 (39.8%)
Ventricular septal defect15 (17%)
Atrial septal defect12 (13.6%)
Musculoskeletal23 (26.1%)
Vertebral abnormality13 (14.8%)
Limb abnormality9 (10.2%)
Genitourinary26 (25%)
Renal abnormality21 (23.9%)
Genital/urinary abnormality5 (1.1%)
Intestinal7 (8%)
Imperforate anus5 (5.7%)
Atresia2 (2.3)
Intracranial/cranial facial9 (10.2%)
Craniofacial abnormality5 (5.7%)
Chromosomal8 (9.1%)
Trisomy 212 (2.3%)
VACTERL association11 (12.5%)
Table 1

Incidence of associated anomalies in neonates with esophageal atresia

AnomalyNumber of cases (%)
Congenital heart disease35 (39.8%)
Ventricular septal defect15 (17%)
Atrial septal defect12 (13.6%)
Musculoskeletal23 (26.1%)
Vertebral abnormality13 (14.8%)
Limb abnormality9 (10.2%)
Genitourinary26 (25%)
Renal abnormality21 (23.9%)
Genital/urinary abnormality5 (1.1%)
Intestinal7 (8%)
Imperforate anus5 (5.7%)
Atresia2 (2.3)
Intracranial/cranial facial9 (10.2%)
Craniofacial abnormality5 (5.7%)
Chromosomal8 (9.1%)
Trisomy 212 (2.3%)
VACTERL association11 (12.5%)
AnomalyNumber of cases (%)
Congenital heart disease35 (39.8%)
Ventricular septal defect15 (17%)
Atrial septal defect12 (13.6%)
Musculoskeletal23 (26.1%)
Vertebral abnormality13 (14.8%)
Limb abnormality9 (10.2%)
Genitourinary26 (25%)
Renal abnormality21 (23.9%)
Genital/urinary abnormality5 (1.1%)
Intestinal7 (8%)
Imperforate anus5 (5.7%)
Atresia2 (2.3)
Intracranial/cranial facial9 (10.2%)
Craniofacial abnormality5 (5.7%)
Chromosomal8 (9.1%)
Trisomy 212 (2.3%)
VACTERL association11 (12.5%)

The main postoperative short-term complications included anastomotic leak (n = 17, 19.3%), pneumothorax (n = 12, 13.6%), and nosocomial infection (n = 10, 11.4%). The most common MTCs included recurrent pulmonary infections (n = 22, 33.3%), anastomotic stricture (n = 21, 31.8%), and gastroesophageal reflux (n = 8, 12.1%) (Table 2). The mortality rate in our series was 25%. The median follow-up in survivors was 7 years (IQR, 3–11 years).

Table 2

Postoperative complications and outcomes

Number of cases (%)
Mortality22 (75%)
Short-term complications38 (43.2%)
Anastomotic leak17 (19.3%)
Pneumothorax12 (13.6%)
Nosocomial infection10 (11.4%)
Surgical site infection9 (10.2%)
Postoperative shock7 (7.9%)
Postoperative sepsis6 (6.8%)
Postoperative MSOF3 (3.4%)
Chylothorax2 (2.3%)
Mid-term complications (in survivors)32 (48.5%)
Recurrent pulmonary infections22 (33.3%)
Anastomotic stricture21 (31.8%)
Gastroesophageal reflux8 (12.1%)
Recurrent fistula3 (4.5%)
Tracheomalacia2 (3%)
LOS (days), median [IQR]§21 [14–26]
Number of cases (%)
Mortality22 (75%)
Short-term complications38 (43.2%)
Anastomotic leak17 (19.3%)
Pneumothorax12 (13.6%)
Nosocomial infection10 (11.4%)
Surgical site infection9 (10.2%)
Postoperative shock7 (7.9%)
Postoperative sepsis6 (6.8%)
Postoperative MSOF3 (3.4%)
Chylothorax2 (2.3%)
Mid-term complications (in survivors)32 (48.5%)
Recurrent pulmonary infections22 (33.3%)
Anastomotic stricture21 (31.8%)
Gastroesophageal reflux8 (12.1%)
Recurrent fistula3 (4.5%)
Tracheomalacia2 (3%)
LOS (days), median [IQR]§21 [14–26]

Defined as complication occurring within 30 days of the operative procedure.

Defined as requiring intervention within 1 year of establishing continuity.

§LOS excludes patients who died.

IQR, interquartile range; LOS, length of stay; MSOF, multiple system organ failure.

Table 2

Postoperative complications and outcomes

Number of cases (%)
Mortality22 (75%)
Short-term complications38 (43.2%)
Anastomotic leak17 (19.3%)
Pneumothorax12 (13.6%)
Nosocomial infection10 (11.4%)
Surgical site infection9 (10.2%)
Postoperative shock7 (7.9%)
Postoperative sepsis6 (6.8%)
Postoperative MSOF3 (3.4%)
Chylothorax2 (2.3%)
Mid-term complications (in survivors)32 (48.5%)
Recurrent pulmonary infections22 (33.3%)
Anastomotic stricture21 (31.8%)
Gastroesophageal reflux8 (12.1%)
Recurrent fistula3 (4.5%)
Tracheomalacia2 (3%)
LOS (days), median [IQR]§21 [14–26]
Number of cases (%)
Mortality22 (75%)
Short-term complications38 (43.2%)
Anastomotic leak17 (19.3%)
Pneumothorax12 (13.6%)
Nosocomial infection10 (11.4%)
Surgical site infection9 (10.2%)
Postoperative shock7 (7.9%)
Postoperative sepsis6 (6.8%)
Postoperative MSOF3 (3.4%)
Chylothorax2 (2.3%)
Mid-term complications (in survivors)32 (48.5%)
Recurrent pulmonary infections22 (33.3%)
Anastomotic stricture21 (31.8%)
Gastroesophageal reflux8 (12.1%)
Recurrent fistula3 (4.5%)
Tracheomalacia2 (3%)
LOS (days), median [IQR]§21 [14–26]

Defined as complication occurring within 30 days of the operative procedure.

Defined as requiring intervention within 1 year of establishing continuity.

§LOS excludes patients who died.

IQR, interquartile range; LOS, length of stay; MSOF, multiple system organ failure.

Multivariate analysis of non-survivor versus survivor groups

Firstly, we performed univariate analysis to select significant variables. Then, the significant risk factors were put in mulitvariate analysis by stepwise selection of variables. Table 3 shows that prematurity, low birth weight, outborn birth, age at admission >12 hours, congenital heart disease, postoperative sepsis, and anastomotic leak were risk factors for mortality following surgical repair of EA.

Table 3

Multivariate analysis of non-survivor versus survivor groups

Nonsurvivor group (N = 22) N %Survivor group (N = 66) N %P-value*Odds ratio*
Male genderYes1568.24466.70.896
No731.82233.3
Prematurity (GA < 37 weeks)Yes836.41015.20.03273.2
No1463.65684.8
Low birth weight (<2500 g)Yes1254.51319.70.0024.892
No1045.55380.3
OutbornYes731.857.60.0045.693
No1568.26192.4
Age at admission >12 hoursYes940.91218.20.0303.115
No1359.15481.8
Congenital heart diseaseYes1463.62131.80.0083.750
No836.44568.2
VACTERL associationYes522.769.10.094
No1777.36090.9
Twin birthYes29.169.11
No20906090.9
Preoperative mechanical ventilationYes940.91827.30.230
No1359.14872.7
Age at surgery >48 hoursYes940.91421.20.069
No1359.15278.8
Anastomotic tensionYes627.3913.60.141
No1672.75786.4
Long gapYes29.169.11
No2090.96090.9
Postoperative sepsisYes418.2230.0157.111
No1881.86497
Anastomotic leakYes836.4913.60.0193.619
No1463.65786.4
Nonsurvivor group (N = 22) N %Survivor group (N = 66) N %P-value*Odds ratio*
Male genderYes1568.24466.70.896
No731.82233.3
Prematurity (GA < 37 weeks)Yes836.41015.20.03273.2
No1463.65684.8
Low birth weight (<2500 g)Yes1254.51319.70.0024.892
No1045.55380.3
OutbornYes731.857.60.0045.693
No1568.26192.4
Age at admission >12 hoursYes940.91218.20.0303.115
No1359.15481.8
Congenital heart diseaseYes1463.62131.80.0083.750
No836.44568.2
VACTERL associationYes522.769.10.094
No1777.36090.9
Twin birthYes29.169.11
No20906090.9
Preoperative mechanical ventilationYes940.91827.30.230
No1359.14872.7
Age at surgery >48 hoursYes940.91421.20.069
No1359.15278.8
Anastomotic tensionYes627.3913.60.141
No1672.75786.4
Long gapYes29.169.11
No2090.96090.9
Postoperative sepsisYes418.2230.0157.111
No1881.86497
Anastomotic leakYes836.4913.60.0193.619
No1463.65786.4

*Value and odds ratio have been bolded if P < 0.05.

GA, gestational age.

Table 3

Multivariate analysis of non-survivor versus survivor groups

Nonsurvivor group (N = 22) N %Survivor group (N = 66) N %P-value*Odds ratio*
Male genderYes1568.24466.70.896
No731.82233.3
Prematurity (GA < 37 weeks)Yes836.41015.20.03273.2
No1463.65684.8
Low birth weight (<2500 g)Yes1254.51319.70.0024.892
No1045.55380.3
OutbornYes731.857.60.0045.693
No1568.26192.4
Age at admission >12 hoursYes940.91218.20.0303.115
No1359.15481.8
Congenital heart diseaseYes1463.62131.80.0083.750
No836.44568.2
VACTERL associationYes522.769.10.094
No1777.36090.9
Twin birthYes29.169.11
No20906090.9
Preoperative mechanical ventilationYes940.91827.30.230
No1359.14872.7
Age at surgery >48 hoursYes940.91421.20.069
No1359.15278.8
Anastomotic tensionYes627.3913.60.141
No1672.75786.4
Long gapYes29.169.11
No2090.96090.9
Postoperative sepsisYes418.2230.0157.111
No1881.86497
Anastomotic leakYes836.4913.60.0193.619
No1463.65786.4
Nonsurvivor group (N = 22) N %Survivor group (N = 66) N %P-value*Odds ratio*
Male genderYes1568.24466.70.896
No731.82233.3
Prematurity (GA < 37 weeks)Yes836.41015.20.03273.2
No1463.65684.8
Low birth weight (<2500 g)Yes1254.51319.70.0024.892
No1045.55380.3
OutbornYes731.857.60.0045.693
No1568.26192.4
Age at admission >12 hoursYes940.91218.20.0303.115
No1359.15481.8
Congenital heart diseaseYes1463.62131.80.0083.750
No836.44568.2
VACTERL associationYes522.769.10.094
No1777.36090.9
Twin birthYes29.169.11
No20906090.9
Preoperative mechanical ventilationYes940.91827.30.230
No1359.14872.7
Age at surgery >48 hoursYes940.91421.20.069
No1359.15278.8
Anastomotic tensionYes627.3913.60.141
No1672.75786.4
Long gapYes29.169.11
No2090.96090.9
Postoperative sepsisYes418.2230.0157.111
No1881.86497
Anastomotic leakYes836.4913.60.0193.619
No1463.65786.4

*Value and odds ratio have been bolded if P < 0.05.

GA, gestational age.

Multivariate analysis of STC versus non-STC groups

Multivariate logistic analyses demonstrated that anastomotic tension was the only factor associated with STC following surgical repair of EA (Table 4).

Table 4

Multivariate analysis of STC versus non-STC groups

STC group (N = 38) N %Non-STC group (N = 50) N %P-value*Odds ratio*
Male genderYes2668.433660.811
No1231.61734
Prematurity (GA < 37 weeks)Yes1026.38160.235
No2873.74284
Low birth weight (<2500 g)Yes1334.212240.293
No2565.83876
OutbornYes718.45100.254
No3181.64590
Age at admission >12 hoursYes1231.69180.139
No2668.44182
Congenital heart diseaseYes195016320.087
No19503468
VACTERL associationYes718.4480.143
No3181.64692
Twin birthYes410.5480.683
No3489.54692
Preoperative mechanical ventilationYes1231.615300.874
No2668.43570
Age at surgery >48 hoursYes1231.611220.311
No2668.43978
Anastomotic tensionYes1128.9480.0104.685
No2771.14692
Long gapYes37.95100.734
No3592.14590
STC group (N = 38) N %Non-STC group (N = 50) N %P-value*Odds ratio*
Male genderYes2668.433660.811
No1231.61734
Prematurity (GA < 37 weeks)Yes1026.38160.235
No2873.74284
Low birth weight (<2500 g)Yes1334.212240.293
No2565.83876
OutbornYes718.45100.254
No3181.64590
Age at admission >12 hoursYes1231.69180.139
No2668.44182
Congenital heart diseaseYes195016320.087
No19503468
VACTERL associationYes718.4480.143
No3181.64692
Twin birthYes410.5480.683
No3489.54692
Preoperative mechanical ventilationYes1231.615300.874
No2668.43570
Age at surgery >48 hoursYes1231.611220.311
No2668.43978
Anastomotic tensionYes1128.9480.0104.685
No2771.14692
Long gapYes37.95100.734
No3592.14590

*P-value and odds ratio have been bolded if P < 0.05.

STC, short-term complication.

Table 4

Multivariate analysis of STC versus non-STC groups

STC group (N = 38) N %Non-STC group (N = 50) N %P-value*Odds ratio*
Male genderYes2668.433660.811
No1231.61734
Prematurity (GA < 37 weeks)Yes1026.38160.235
No2873.74284
Low birth weight (<2500 g)Yes1334.212240.293
No2565.83876
OutbornYes718.45100.254
No3181.64590
Age at admission >12 hoursYes1231.69180.139
No2668.44182
Congenital heart diseaseYes195016320.087
No19503468
VACTERL associationYes718.4480.143
No3181.64692
Twin birthYes410.5480.683
No3489.54692
Preoperative mechanical ventilationYes1231.615300.874
No2668.43570
Age at surgery >48 hoursYes1231.611220.311
No2668.43978
Anastomotic tensionYes1128.9480.0104.685
No2771.14692
Long gapYes37.95100.734
No3592.14590
STC group (N = 38) N %Non-STC group (N = 50) N %P-value*Odds ratio*
Male genderYes2668.433660.811
No1231.61734
Prematurity (GA < 37 weeks)Yes1026.38160.235
No2873.74284
Low birth weight (<2500 g)Yes1334.212240.293
No2565.83876
OutbornYes718.45100.254
No3181.64590
Age at admission >12 hoursYes1231.69180.139
No2668.44182
Congenital heart diseaseYes195016320.087
No19503468
VACTERL associationYes718.4480.143
No3181.64692
Twin birthYes410.5480.683
No3489.54692
Preoperative mechanical ventilationYes1231.615300.874
No2668.43570
Age at surgery >48 hoursYes1231.611220.311
No2668.43978
Anastomotic tensionYes1128.9480.0104.685
No2771.14692
Long gapYes37.95100.734
No3592.14590

*P-value and odds ratio have been bolded if P < 0.05.

STC, short-term complication.

Multivariate analysis of MTC versus non-MTC groups

The comparison of MTC and non-MTC groups revealed that the occurrence of a postoperative short-term complication was the only predictive factor of MTCs (Table 5).

Table 5

Multivariate analysis of MTC versus non-MTC groups

MTC group (N = 32) N %Non-MTC group (N = 34) N %P-value*Odds ratio*
Male genderYes2371.92161.80.384
No928.11338.2
Prematurity (GA < 37 weeks)Yes412.5617.60.560
No2887.52882.4
Low birth weight (<2500 g)Yes721.9617.60.666
No2578.12882.4
OutbornYes26.238.80.693
No3093.83191.2
Age at admission >24 hYes412.5823.50.246
No2887.52676.5
Congenital heart diseaseYes1134.41029.40.665
No2165.62470.6
VACTERL associationYes412.525.90.350
No2887.53294.1
Twin birthYes39.438.80.938
No2990.63191.2
Preoperative mechanical ventilationYes618.71235.30.131
No2681.32264.7
Age at surgery >48 hYes618.7823.50.635
No2681.32676.5
Anastomotic tensionYes721.9411.80.271
No2578.13088.2
Occurrence of a STCYes24751441.20.0053.002
No8252058.8
MTC group (N = 32) N %Non-MTC group (N = 34) N %P-value*Odds ratio*
Male genderYes2371.92161.80.384
No928.11338.2
Prematurity (GA < 37 weeks)Yes412.5617.60.560
No2887.52882.4
Low birth weight (<2500 g)Yes721.9617.60.666
No2578.12882.4
OutbornYes26.238.80.693
No3093.83191.2
Age at admission >24 hYes412.5823.50.246
No2887.52676.5
Congenital heart diseaseYes1134.41029.40.665
No2165.62470.6
VACTERL associationYes412.525.90.350
No2887.53294.1
Twin birthYes39.438.80.938
No2990.63191.2
Preoperative mechanical ventilationYes618.71235.30.131
No2681.32264.7
Age at surgery >48 hYes618.7823.50.635
No2681.32676.5
Anastomotic tensionYes721.9411.80.271
No2578.13088.2
Occurrence of a STCYes24751441.20.0053.002
No8252058.8

Excluding patients who died.

*P-value and odds ratio have been bolded if P < 0.05.

GA, gestational age; STC, short-term complication.

Table 5

Multivariate analysis of MTC versus non-MTC groups

MTC group (N = 32) N %Non-MTC group (N = 34) N %P-value*Odds ratio*
Male genderYes2371.92161.80.384
No928.11338.2
Prematurity (GA < 37 weeks)Yes412.5617.60.560
No2887.52882.4
Low birth weight (<2500 g)Yes721.9617.60.666
No2578.12882.4
OutbornYes26.238.80.693
No3093.83191.2
Age at admission >24 hYes412.5823.50.246
No2887.52676.5
Congenital heart diseaseYes1134.41029.40.665
No2165.62470.6
VACTERL associationYes412.525.90.350
No2887.53294.1
Twin birthYes39.438.80.938
No2990.63191.2
Preoperative mechanical ventilationYes618.71235.30.131
No2681.32264.7
Age at surgery >48 hYes618.7823.50.635
No2681.32676.5
Anastomotic tensionYes721.9411.80.271
No2578.13088.2
Occurrence of a STCYes24751441.20.0053.002
No8252058.8
MTC group (N = 32) N %Non-MTC group (N = 34) N %P-value*Odds ratio*
Male genderYes2371.92161.80.384
No928.11338.2
Prematurity (GA < 37 weeks)Yes412.5617.60.560
No2887.52882.4
Low birth weight (<2500 g)Yes721.9617.60.666
No2578.12882.4
OutbornYes26.238.80.693
No3093.83191.2
Age at admission >24 hYes412.5823.50.246
No2887.52676.5
Congenital heart diseaseYes1134.41029.40.665
No2165.62470.6
VACTERL associationYes412.525.90.350
No2887.53294.1
Twin birthYes39.438.80.938
No2990.63191.2
Preoperative mechanical ventilationYes618.71235.30.131
No2681.32264.7
Age at surgery >48 hYes618.7823.50.635
No2681.32676.5
Anastomotic tensionYes721.9411.80.271
No2578.13088.2
Occurrence of a STCYes24751441.20.0053.002
No8252058.8

Excluding patients who died.

*P-value and odds ratio have been bolded if P < 0.05.

GA, gestational age; STC, short-term complication.

DISCUSSION

In this study, the diagnosis of EA was suspected prenatally in 21.6% of cases. This was in accordance with previous studies that reported a 20–30% rate of prenatal diagnosis of EA.15

Most of our patients (77.3%) had type III EA, whereas only one neonate (1.1%) had type II EA. The distribution of anatomical types of EA was similar to previous studies.16–18

We identified associated anomalies in 55.7% of our patients with 39.8% having congenital heart diseases. These results are similar to those reported by other studies.5,7,13,19,20 In accordance with our results, many authors demonstrated that these malformations are a strong predictive factor of mortality following surgical repair of EA.5,7,21,22 However, based on a nationwide analysis of clinical outcomes among neonates with EA, Wang et al.23 suggested that only major cardiac malformations should be considered as predictive factors of death in EA. In addition to the known VACTERL association including vertebral, anorectal, cardiac, tracheoesophageal, renal, and limb abnormalities, we found intracranial/cranial facial anomalies in nine (10.2%) patients and chromosomal abnormalities in 9.1% of patients. These rates are higher than those reported by Keckler et al.,24 which were 5% and 4%, respectively. Therefore, we suggest that a comprehensive work-up is critical to identify the associated anomalies in neonates with EA.

In our series, 22 (25%) patients died following surgical management of EA. While the survival rate after surgical treatment of EA is greater than 90% in high-income countries, the mortality rate is still high in low-income countries, ranging from 25 to 40%.3,7,13,21,25–30 Recent advances in perinatal resuscitation and neonatal care have led to significant improvements in survival in developed countries.21,23,31,32 However, EA remains an important cause of mortality in low-income countries.13,32,33 The main cause that could explain the high mortality rate in our study is the absence of neonatal intensive care and pediatric surgery units in the vast majority of hospitals in southern Tunisia. In accordance with this idea, we found that neonates born outside our institution had a significantly higher mortality rate. This could be explained by the delayed diagnosis in these patients. Our institution, as an academic referral hospital, is the only institution in southern Tunisia that provides neonatal intensive care and pediatric surgery services. It covers an area of 100,000 km2 and a population of 3 million inhabitants. Surgical care in low-income countries has many challenges including delayed presentation, poor infrastructure, and lack of trained personnel. Ekenze et al.34 confirmed these difficulties based on a literature review including all publications on neonatal surgery in Africa over 20 years. The authors recommended some strategies to overcome these challenges. These strategies include improving health-care funding, implementing policies that facilitate interprofessional collaboration, making neonatal intensive care cost effective, and promoting focused international collaboration.

Our study revealed that prematurity, low birth weight, outborn birth, age at admission >12 hours, congenital heart disease, postoperative sepsis, and anastomotic leak were associated with mortality following surgical repair of EA. These results were similar to other studies.22,33,35,36

Interestingly, postoperative sepsis was the strongest risk factor for mortality following surgical repair of EA. Neonatal sepsis is the third most common cause of mortality in neonates and a growing public health problem, especially in low-income countries.37 Several factors including prematurity, delayed diagnosis, and anastomotic leak contribute to sepsis-related death following surgical repair of EA.13,31–33,35

This study found that nosocomial infections were the most common infectious postoperative complication. Nosocomial infections are common in neonatal intensive care units. According to many authors, vascular catheters, high-calorie hyperalimentation infusions, assisted ventilation, and prior use of antibiotics are significant risk factors for neonatal nosocomial infections. Therefore, strategies including hand hygiene before and after patient contact, use of maternal breast milk, and implementation of quality improvement programs are critical to preventing neonatal nosocomial infections and improving the prognosis of these patients.38,39

This study pointed out the role of anastomotic tension as the only risk factor for STC following surgical repair of EA. This is in accordance with most studies suggesting that the presence of a long gap between the two esophageal ends, with consequent anastomotic tension is an important risk factor for postoperative complications, including anastomotic leak and infectious complications.12,13,21,27

The occurrence of STC was the only predictor of MTC in our study. This is in agreement with published literature data. Anastomotic leak and long gap, particularly, has been identified by many authors as important risk factors for anastomotic stricture.40,41

Our study is one of the few studies conducted in low-income countries that focused on risk factors for mortality and morbidity following surgical repair of EA. The identification of these factors may help develop diagnostic, therapeutic, and preventive strategies for early detection and management of adverse outcomes in neonates with EA. This could significantly improve the prognosis of these patients. However, the findings of this study should be considered in light of some limitations. Firstly, it was a retrospective observational study. Therefore, bias and errors in data extraction were possible. Moreover, the retrospective design of our study and the limited follow-up for some patients made it difficult to assess long-term complications following surgical repair of EA. Secondly, the present study was monocentric; so, our results are not necessarily representative of all patients with EA in Tunisia. We believe that further prospective multicenter cohort studies are needed to validate the identified risk factors. The final limitation of our study was the relatively small sample size.

CONCLUSION

This study provides physicians and families with contemporary information regarding risk factors for adverse outcomes following surgical repair of EA. Our study demonstrated that prematurity, low birth weight, outborn birth, age at admission >12 hours, congenital heart disease, postoperative sepsis, and anastomotic leak were risk factors for mortality. Anastomotic tension was predictive of STC and the occurrence of STC was predictive of MTC. Thus, any effort to reduce these risk factors would be critical to improving patient outcomes and reducing cost. Future multi-institutional studies are needed to identify, investigate, and establish best practices and clinical care guidelines for neonates with EA.

Conflicts of interest: The authors declare that they have no conflict of interest

References

1.

Kim
 
N E
,
Vervoot
 
D
,
Hammouri
 
A
 et al.  
Cost-effectiveness of neonatal surgery for congenital anomalies in low-income and middle-income countries: a systematic review protocol
.
BMJ Paediatr Open
 
2020
;
4
(
1
): e000755.

2.

Sitkin
 
N A
,
Farmer
 
D L
.
Congenital anomalies in the context of global surgery
.
Semin Pediatr Surg
 
2016
;
25
:
15
8
.

3.

Pedersen
 
R N
,
Calzolari
 
E
,
Husby
 
S
 et al.  
Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions
.
Arch Dis Child
 
2012
;
97
:
227
32
.

4.

Oddsberg
 
J
,
Lu
 
Y
,
Lagergren
 
J
.
Aspects of esophageal atresia in a population-based setting: incidence, mortality, and cancer risk
.
Pediatr Surg Int
 
2012
;
28
:
249
57
.

5.

Sfeir
 
R
,
Bonnard
 
A
,
Khen-Dunlop
 
N
 et al.  
Esophageal atresia: data from a national cohort
.
J Pediatr Surg
 
2013
;
48
:
1664
9
.

6.

Leoncini
 
E
,
Bower
 
C
,
Nassar
 
N
.
Oesophageal atresia and tracheo-oesophageal fistula in Western Australia: prevalence and trends
.
J Paediatr Child Health
 
2015
;
51
:
1023
9
.

7.

Ammar
 
S
,
Sellami
 
S
,
Sellami
 
I
 et al.  
Management of esophageal atresia and early predictive factors of mortality and morbidity in a developing country
.
Dis Esophagus
 
2019
;
32
(
6
): doy135.

8.

Schmedding
 
A
,
Wittekindt
 
B
,
Schloesser
 
R
 et al.  
Outcome of esophageal atresia in Germany
.
Dis Esophagus
 
2021
;
34
(
4
): doaa093.

9.

Schlee
 
D
,
Theilen
 
T M
,
Fiegel
 
H
 et al.  
Outcome of esophageal atresia: inborn versus outborn patients
.
Dis Esophagus
 
2022
; doab092  
Online ahead of print
.

10.

Wang
 
J
,
Zhang
 
M
,
Pan
 
W
 et al.  
Management of recurrent tracheoesophageal fistula after esophageal atresia and follow-up
.
Dis Esophagus
 
2017
;
30
(
9
):
1
8
.

11.

Francesca
 
B
,
Benedetta
 
R
,
Andrea
 
C
 et al.  
Neurodevelopmental outcome in infants with esophageal atresia: risk factors in the first year of life
.
Dis Esophagus
 
2021
;
34
(
5
): doaa102.

12.

Dingemann
 
C
,
Dietrich
 
J
,
Zeidler
 
J
 et al.  
Early complications after esophageal atresia repair: analysis of a German health insurance database covering a population of 8 million
.
Dis Esophagus
 
2016
;
29
(
7
):
780
6
.

13.

Bouguermouh
 
D
,
Salem
 
A
.
Esophageal atresia: a critical review of management at a single center in Algeria
.
Dis Esophagus
 
2015
;
28
(
3
):
205
10
.

14.

Van Hoorn
 
C E
,
Ten Kate
 
C A
,
Rietman
 
A B
 et al.  
Long-term neurodevelopment in children born with esophageal atresia: a systematic review
.
Dis Esophagus
 
2021
;
34
(
11
): doab054.

15.

Pardy
 
C
,
D'Antonio
 
F
,
Khalil
 
A
 et al.  
Prenatal detection of esophageal atresia: a systematic review and meta-analysis
.
Acta Obstet Gynecol Scand
 
2019
;
98
(
6
):
689
99
.

16.

Spitz
 
L
.
Oesophageal atresia
.
Orphanet J Rare Dis
 
2007
;
2
:
24
.

17.

Evanovich
 
D M
,
Wang
 
J T
,
Zendejas
 
B
 et al.  
From the ground up: esophageal atresia types, disease severity stratification and survival rates at a single institution
.
Front Surg
 
2022
;
9
: 799052.

18.

Bogs
 
T
,
Zwink
 
N
,
Chonitzki
 
V
 et al.  
Esophageal atresia with or without tracheoesophageal fistula (EA/TEF): association of different EA/TEF subtypes with specific co-occurring congenital anomalies and implications for diagnostic workup
.
Eur J Pediatr Surg
 
2018
;
28
(
2
):
176
82
.

19.

Lautz
 
T B
,
Mandelia
 
A
,
Radhakrishnan
 
J
.
VACTERL associations in children undergoing surgery for esophageal atresia and anorectal malformations: Implications for pediatric surgeons
.
J Pediatr Surg
 
2015
;
50
(
8
):
1245
50
.

20.

Stenström
 
P
,
Salö
 
M
,
Anderberg
 
M
 et al.  
Congenital heart disease and its impact on the development of anastomotic strictures after reconstruction of esophageal atresia
.
Gastroenterol Res Pract
 
2018
;
2018
:
6021014
.

21.

Sulkowski
 
J P
,
Cooper
 
J N
,
Lopez
 
J J
 et al.  
Morbidity and mortality in patients with esophageal atresia
.
Surgery
 
2014
;
156
(
2
):
483
91
.

22.

Lazow
 
S P
,
Ben-Ishay
 
O
,
Aribindi
 
V K
 et al.  
Predictors of index admission mortality and morbidity in contemporary esophageal atresia patients
.
J Pediatr Surg
 
2020
;
55
(
11
):
2322
8
.

23.

Wang
 
B
,
Tashiro
 
J
,
Allan
 
B J
 et al.  
A nationwide analysis of clinical outcomes among newborns with esophageal atresia and tracheoesophageal fistulas in the United States
.
J Surg Res
 
2014
;
190
:
604
12
.

24.

Keckler
 
S J
,
St Peter
 
S D
,
Valusek
 
P A
 et al.  
VACTERL anomalies in patients with esophageal atresia: an updated delineation of the spectrum and review of the literature
.
Pediatr Surg Int
 
2007
;
23
:
309
13
.

25.

Ishimaru
 
T
,
Fujiogi
 
M
,
Michihata
 
N
 et al.  
Impact of congenital heart disease on outcomes after primary repair of esophageal atresia: a retrospective observational study using a nationwide database in Japan
.
Pediatr Surg Int
 
2019
;
35
(
10
):
1077
83
.

26.

Alshehri
 
A
,
Lo
 
A
,
Baird
 
R
.
An analysis of early nonmortality outcome prediction in esophageal atresia
.
J Pediatr Surg
 
2012
;
47
(
5
):
881
4
.

27.

Davari
 
H A
,
Hosseinpour
 
M
,
Nasiri
 
G M
 et al.  
Mortality in esophageal atresia: assessment of probable risk factors (10 years' experience)
.
J Res Med Sci
 
2012
;
17
(
6
):
540
2
.

28.

Sfeir
 
R
,
Rousseau
 
V
,
Bonnard
 
A
 et al.  
Risk factors of early mortality and morbidity in esophageal atresia with distal tracheoesophageal fistula: a population-based cohort study
.
J Pediatr
 
2021
;
234
:
99
105.e1
.

29.

Tandon
 
R K
,
Sharma
 
S
,
Sinha
 
S K
 et al.  
Esophageal atresia: factors influencing survival - experience at an Indian tertiary centre
.
J Indian Assoc Pediatr Surg
 
2008
;
13
(
1
):
2
6
.

30.

Peters
 
R T
,
Ragab
 
H
,
Columb
 
M O
 et al.  
Mortality and morbidity in oesophageal atresia
.
Pediatr Surg Int
 
2017
;
33
(
9
):
989
94
.

31.

Lal
 
D R
,
Gadepalli
 
S K
,
Downard
 
C D
 et al.  
Challenging surgical dogma in the management of proximal esophageal atresia with distal tracheoesophageal fistula: outcomes from the Midwest pediatric surgery consortium
.
J Pediatr Surg
 
2018
;
53
(
7
):
1267
72
.

32.

van
 
Hoorn
 
C E
,
Costerus
 
S A
,
Lau
 
J
 et al.  
Perioperative management of esophageal atresia/tracheo-esophageal fistula: an analysis of data of 101 consecutive patients
.
Paediatr Ansaesth
 
2019
;
29
(
10
):
1024
32
.

33.

Li
 
X W
,
Jiang
 
Y J
,
Wang
 
W X
 et al.  
A scoring system to predict mortality in infants with esophageal atresia: a case-control study
.
Medicine (Baltimore)
 
2017
;
96
(
32
): e7755.

34.

Ekenze
 
S O
,
Ajuzieogu
 
O V
,
Nwomeh
 
B C
.
Challenges of management and outcome of neonatal surgery in Africa: a systematic review
.
Pediatr Surg Int
 
2016
;
32
(
3
):
291
9
.

35.

Hew
 
N L C
,
Grover
 
Z
,
Paida
 
S
 et al.  
Predictors of poor outcomes in children with tracheoesophageal fistula/oesophageal atresia: an Australian experience
.
World J Paediatr Surg
 
2021
;
4
: e000190.

36.

Tan Tanny
 
S P
,
Fearon
 
E
,
Hawley
 
A
 et al.  
Predictors of mortality after primary discharge from hospital in patients with esophageal atresia
.
J Pediatr
 
2020
;
219
:
70
5
.

37.

Zea-Vera
 
A
,
Ochoa
 
T J
.
Challenges in the diagnosis and management of neonatal sepsis
.
J Trop Pediatr
 
2015
;
61
(
1
):
1
13
.

38.

Wang
 
L
,
Du
 
K N
,
Zhao
 
Y L
 et al.  
Risk factors of nosocomial infection for infants in neonatal intensive care units: a systematic review and meta-analysis
.
Med Sci Monit
 
2019
;
25
:
8213
20
.

39.

Jansen
 
S J
,
Lopriore
 
E
,
van der
 
Beek
 
M T
 et al.  
The road to zero nosocomial infections in neonates-a narrative review
.
Acta Paediatr
 
2021
;
110
(
8
):
2326
35
.

40.

Koivusalo
 
A
,
Mutanen
 
A
,
Suominen
 
J
 et al.  
Anastomotic stricture in end-to-end anastomosis-risk factors in a series of 261 patients with esophageal atresia
.
Eur J Pediatr Surg
 
2022
;
32
(
1
):
56
60
.

41.

Vergouwe
 
F W T
,
Vlot
 
J
,
Ijsselstijn
 
H
 et al.  
Risk factors for refractory anastomotic strictures after oesophageal atresia repair: a multicentre study
.
Arch Dis Child
 
2019
;
104
(
2
):
152
7
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)